#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15388	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2072	733.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1690	1690	T	811	T,C	749,5	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15388	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2072	733.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1424	1424	C	924	C	864	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15388	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2072	733.4	0	HET	.	.	.	A322G	.	322	322	A	562	562	A	870	A,G	610,196	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27928	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3696	750.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1747	1747	A	1010	A	939	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27928	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3696	750.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2381	2381	C	908	C,G	844,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27928	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3696	750.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2455	2455	A	829	A	789	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27928	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3696	750.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3007	3007	C	876	C,A	825,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2088	folP	855	855	100.0	folP.l15.c4.ctg.1	1446	142.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1021	1023	AGC	195;193;193	A,C;G;C	183,1;183;182	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5696	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3483	162.3	1	SNP	p	S91F	1	.	.	271	273	TTC	656	658	TTC	190;192;194	T;T,C;C	179;182,1;180	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5696	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3483	162.3	1	SNP	p	G95N	0	.	.	283	285	GGC	668	670	GGC	196;192;196	G;G,A;C	182;170,1;181	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5696	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3483	162.3	1	SNP	p	D95G	1	.	.	283	285	GGC	668	670	GGC	196;192;196	G;G,A;C	182;170,1;181	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1674	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1314	126.0	1	SNP	p	G45D	0	.	.	133	135	GGC	493	495	GGC	215;213;212	G;G;C	200;198;201	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	876	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	895	96.8	0	.	n	.	0	A197.	DEL	197	197	A	538	538	A	203	A,C	187,1	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5298	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2964	176.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1455	1457	GTC	196;196;195	G;T;C	182;181;179	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5298	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2964	176.9	1	SNP	p	D86N	0	.	.	256	258	GAC	561	563	GAC	201;200;200	G;A,C;C	187;178,1;185	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5298	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2964	176.9	1	SNP	p	R87W	0	.	.	259	261	CGT	564	566	CGT	203;202;203	C;G;T	188;187;182	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5298	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2964	176.9	1	SNP	p	R87I	0	.	.	259	261	CGT	564	566	CGT	203;202;203	C;G;T	188;187;182	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5298	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2964	176.9	1	SNP	p	S87R	1	.	.	259	261	CGT	564	566	CGT	203;202;203	C;G;T	188;187;182	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5298	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2964	176.9	1	SNP	p	S88P	0	.	.	262	264	TCC	567	569	TCC	207;207;210	T;C;C	194;192;193	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4636	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2537	181.1	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1268	1270	TGC	216;214;209	T;G;C	199;201;199	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4636	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2537	181.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1478	1480	GGC	202;198;194	G;G;C	184;179;180	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1250	1252	GCA	226;229;226	G;C;A	214;213;212	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1253	1255	ATC	225;225;226	A;T;C	212;210;212	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1265	1267	GTG	237;239;234	G;T;G	225;224;222	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1265	1267	GTG	237;239;234	G;T;G	225;224;222	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1769	1771	ACC	246;245;246	A;C;C	220;227;231	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1823	1825	GCG	209;212;214	G;C;G	191;175;181	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1823	1825	GCG	209;212;214	G;C;G	191;175;181	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1946	1948	GGC	233;233;231	G;G;C	213;215;212	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1955	1957	GGC	229;227;226	G;G;C	204;205;201	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2308	196.5	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1973	1975	TCG	205;205;203	T,G;C;G	132,9;164;160	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6048	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2964	202.5	0	.	p	.	0	E418G	NONSYN	1252	1254	GAG	1552	1554	GGG	240;243;246	G;G;G,A	223;229;228,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6048	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2964	202.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1561	1563	CCG	242;241;237	C;C;G	219;226;220	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2278	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1908	118.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	571	571	C	177	C	158	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3058	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1519	198.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	389	391	GAA	224;224;220	G;A;A	211;211;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3058	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1519	198.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	677	679	GAT	292;299;301	G;A;T	274;283;286	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3058	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1519	198.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	800	802	TCA	281;283;285	T;C;A	265;266;272	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3058	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1519	198.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	929	931	GTC	253;253;253	G,A;T;C,G	239,1;241;241,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3058	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1519	198.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1259	1261	GCA	215;215;214	G;C,A;A	205;204,1;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3058	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1519	198.9	1	SNP	p	G120K	1	.	.	358	360	AAG	635	637	AAG	275;271;270	A;A;G	257;254;254	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3058	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1519	198.9	1	SNP	p	D121N	0	.	.	361	363	GAC	638	640	GAC	269;266;266	G,T;A;C	251,1;251;251	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3058	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1519	198.9	1	SNP	p	A121D	1	.	.	361	363	GAC	638	640	GAC	269;266;266	G,T;A;C	251,1;251;251	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11060	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4894	224.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1991	1993	AAT	249;250;248	A;A;T	233;235;231	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1186	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	905	129.5	1	SNP	p	V57M	1	.	.	169	171	ATG	442	444	ATG	247;248;251	A;T;G	237;236;241	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
